Chemical profile, acetylcholinesterase, butyrylcholinesterase, and prolyl oligopeptidase inhibitory activity of Glaucium corniculatum subsp. refractum

Autores

  • Buket Bozkurt Department of Pharmacognosy, Faculty of Pharmacy, Ege University, Izmir, Turkey https://orcid.org/0000-0003-2858-5162
  • Duygu Ulkar Department of Pharmacognosy, Faculty of Pharmacy, Ege University, Izmir, Turkey
  • Necati Nurlu Department of Pharmacognosy, Faculty of Pharmacy, Ege University, Izmir, Turkey
  • Gulen Irem Kaya Department of Pharmacognosy, Faculty of Pharmacy, Ege University, Izmir, Turkey
  • Gulen Irem Kaya Department of Pharmacognosy, Faculty of Pharmacy, Ege University, Izmir, Turkey
  • Nehir Unver-Somer Department of Pharmacognosy, Faculty of Pharmacy, Ege University, Izmir, Turkey

DOI:

https://doi.org/10.1590/s2175-97902022e20464

Palavras-chave:

Glaucium corniculatum, Anticholinesterase, POP inhibitory activity, GC-MS

Resumo

Papaveraceae is one of the prominent alkaloid-containing families, and plants of the genus Glaucium (Papaveraceae) are known for their bioactive alkaloids. Glaucium species have been used in traditional medicine in Turkey as an analgesic, narcotic, sedative, and antitussive. In this study, it was planned to evaluate the inhibitory activity of an alkaloidal extract of Glaucium corniculatum subsp. refractum on acetylcholinesterase (AChE), butyrylcholinesterase (BuChE) and prolyl oligopeptidase (POP), as well as exploring the chemical profile of the plant by using Gas Chromatography-Mass Spectrometry (GC-MS). The AChE, BuChE and POP inhibition activities of the alkaloidal extract of G. corniculatum subsp. refractum were determined spectrophotometrically. A rapid GC-MS method was used to identify alkaloids that could be responsible for these inhibition activities. In total, eleven alkaloids were identified in the alkaloid extract of the plant by GC-MS. Allocyptopine (52.92%) and protopine (25.38%) were found as the major constituents. The alkaloidal extract of G. corniculatum subsp. refractum showed potent AChE inhibitory activity (IC50:1.25 µg/mL) and BuChE inhibitory activity (IC50: 7.02 µg/mL). The extract also showed a remarkable inhibitory effect on POP with an IC50 value of 123.69 µg/mL. This study presents the first GC-MS investigation and POP inhibitory activity of G. corniculatum subsp. refractum.

Downloads

Os dados de download ainda não estão disponíveis.

Referências

Ahmad S, Ayaz M, Murkovic M. Characterization of phenolic compounds using UPLC-HRMS and HPLC-DAD and anticholinesterase and antioxidant activities of Trifolium repens L. leaves. Eur Food Res Technol. 2020;246:485-496.

Allafchian AR, Jalali SAH, Aghaei F, Farhang HR. Green synthesis of silver nanoparticles using Glaucium corniculatum (L.) Curtis extract and evaluation of its antibacterial activity. IET Nanobiotechnol. 2018;12(5):574-578.

Anand P, Singh, B. A review on cholinesterase inhibitors for Alzheimer’s disease. Arch Pharmacol. Res. 2013;36(4):375- 399.

Ayaz M, Junaid M, Ullah F, Subhan F, Sadiq A, Ali G, et al. Comparative chemical profiling, cholinesterase inhibitions and anti-radicals properties of essential oils from Polygonum hydropiper L: A Preliminary anti-Alzheimer’s study. Lipids Health Dis. 2015;14:141.

Bajic V, Milovanovic ES, Spremo-Potparevic B, Zivkovic L, Milicevic Z, Stanimirovic J, et al. Treatment of Alzheimer’s disease: Classical therapeutic approach. Curr Pharm Anal. 2016;12(2):82-90.

Baytop T. Therapy with medicinal plants in Turkey (Past and Present), Istanbul, Istanbul University Press. 1984.

Bozkurt-Sarikaya B, Somer N, Kaya GI, Onur MA, Bastida J, Berkov S. GC-MS investigation and acetylcholinesteraseInhibitory activity of Galanthus rizehensis Z Naturforsch C J Biosci. 2013;68(3-4),118-124.

Cahlíková L, Hulová L, Hrabinová M, Chlebek J, Hošťálková A, Adamcová M, et al. Isoquinoline alkaloids as prolyl oligopeptidase inhibitors. Fitoterapia. 2015;103:192-196.

Chia YC, Chang FR, Wu CC, Teng CM, Chen KS, Wu YC. Effect of isoquinoline alkaloids of different structural types on antiplatelet aggregation in vitro. Planta Med. 2006;72(13):1238-1241.

Chlebek J, Macáková K, Cahlíkovi L, Kurfürst M, Kunes J, Opletal L. Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Corydalis cava (Fumariaceae). Nat Prod Commun. 2011;6(5):607-610.

Constant O, Slavin B, Lehane JR, Jordan C, Jones JG. Effect of antitussive glaucine on broncohomotor tone in man. Thorax. 1983;38(7):537-542.

Cortijo J, Villagrasa V, Pons R, Berto L, Marti-Cabrera M, Martinez-Losa M, et al. Bronchodilator and anti-inflammatory activities of glausine: in vitro studies in human airway smooth muscle and polymorphonuclear leukocytes. Br J Pharmacol. 1999;127(7):1641-1651.

Davis PH, Mill RR, Tan K. Flora of Turkey and the East Aegean Islands. Vol. 10. Edinburgh, Edinburgh Univ. Press. 1988.

Doncheva T, Kostova N, Yordanova G, Saadi H, Akrib F, Dimitrov D, et al. Comparison of alkaloid profile from Glaucium corniculatum (Papaveraceae) of Algerian and Bulgarian origin. Biochem Syst Ecol. 2014;56:278-280.

Ellman L, Courtney KD, Andres VJr, Featherstone RM. New and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7(2):88-95.

Erbay MS, Anıl S, Melikoglu G. Plants used as painkiller in traditional treatment in Turkey - II headache. Marmara Pharm J. 2018;22(1):29-36.

Greig NH, Lahiri DK, Sambamurti K. Butyrylcholinesterase: An important new target in Alzheimer’s disease therapy. Int Psychogeriatr. 2002;14(1):77-91.

Han N, Yang Z, Liu Z, Liu H, Yin J. Research progress on natural benzophenanthridine alkaloids and their pharmacological functions: A review. Nat Prod Commun . 2016;11(8):1181-1188.

Hayta S, Polat R, Selvi S. Traditional uses of medicinal plants in Elazig (Turkey). J Ethnopharmacol. 2014;154(3):613-623.

Ibrahim MM, Gabr MT. Multitarget therapeutic strategies for Alzheimer’s disease. Neural Regen Res. 2019;14(3):437-440.

Kato A, Fukunari A, Sakai Y, Nakajima Z. Prevention of amyloid-like deposition by a selective prolyl endopeptidase inhibitor, Y-29794, in senescence-accelerated mouse. J Pharmacol Exp Ther. 1997;283(1):328-335.

Kilic FM, Yildi K, Kilic M. Habitat properties of some Glaucium Mill. (Papaveraceae) taxa spreading in Turkey. Turk J Life Sci. 2018;3(2):255-262.

Kintsurashvili LG, Vachnadze VY. Alkaloids of Glaucium corniculatum and G. flavum growing in Georgia. Chem Nat Compd. 2000;36(2):225-226.

Kreh M, Matusch R, Witte L. Capillary gas chromatography-mass spectrometry of Amaryllidaceae alkaloids. Phytochemistry. 1995;38(3):773-776.

Mesulam M, Guillozet A, Shaw P, Quinn B. Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain. Neurobiol Dis. 2002;9(1):88-93.

Novák V, Dolejš L, Slavík J. Alkaloids of the Papaveraceae. XLVIII. (-)-Stylopine methohydroxide, a new alkaloid from Glaucium corniculatum CURT. Collect Czech Chem Commun. 1972;37(10):3346-3349.

Orhan I, Sener B, Choudhary MI, Khalid B. Acetylcholinesterase and butyrylcholinesterase inhibitory activity of some Turkish medicinal plants. J Ethnopharmacol . 2004;91(1):57-60.

Opletal L, Ločárek M, Fraňková A, Chlebek J, Šmíd J, Hošťálková A, et al. Antimicrobial Activity of extracts and isoquinoline alkaloids of selected Papaveraceae plants. Nat Prod Commun . 2014;9(12):1709-1712.

Petitto V, Serafini M, Gallo FR, Multari G, Nicoletti M. Alkaloids from Glaucium flavum from Sardinia. Nat Prod Res. 2010;24(11):1033-1035.

Pinho BR, Federico F, Valentão P, Andrade PB. Nature as a source of metabolites with cholinesterase inhibitory activity: An approach to Alzheimer’s disease treatment. J Pharm Pharmacol. 2013;65(12):1681-1700.

Pinto L, Borrelli F, Bombardelli E, Cristoni A, Capasso F. Anti-inflammatory, analgesic and antipyretic effects of glaucine in rats and mice. Pharm Pharmacol Commun. 1998;4(10):502-505.

Polgár L. The prolyl oligopeptidase family. Cell Mol Life Sci. 2002;59(2):349-362.

Prince M, Wimo A, Guerchet M, Ali G, Wu Y, Prina M. The global impact of dementia: an analysis of prevalence, incidence, cost and trends. Alzheimer’s Disease International, World Alzheimer’s Report. London. 2015.

Rossner S, Schulz I, Zeitschel U, Schliebs R, Bigl V, Demuth HU. Brain prolyl endopeptidase in aging, APP transgenic mice and Alzheimer’s disease. Neurochem Res. 2005;30(6-7):695-702.

Sargin SA. Ethnobotanical survey of medicinal plants in Bozyazi district of Mersin, Turkey. J Ethnopharmacol . 2015;173(15):105-126.

Shafiee A, Ghanbarpour A, Akhlaghi S. Alkaloids of Papaveraceae, XII. Alkaloids of Glaucium corniculatum subspecies refractum, population Pol-Dokhtar. J Nat Prod. 1985;48(5):855-856.

Shamma M, Slusarchyk WA. The aporphine alkaloids. Chem Rev. 1964;64(1):59-79.

Xu Z, Deng M. Identification and Control of Common Weeds, Vol. 2. Netherlands: Springer; 2017. 415-432p.

Vacek J, Walterová D, Vrublová E, Šimánek V. The chemical and biological properties of protopine and allocryptopine. Heterocycles. 2010;81(8):1773-1789.

Yoshimoto T, Kado K, Matsubara F, Koriyama N, Kaneto H, Tsuru D. Specific inhibitors for prolyl endopeptidase and their anti-amnesic effect. J Pharmacobiodyn. 1987;10(12):730-735.

Downloads

Publicado

2022-12-23

Edição

Seção

Original Article

Como Citar

Chemical profile, acetylcholinesterase, butyrylcholinesterase, and prolyl oligopeptidase inhibitory activity of Glaucium corniculatum subsp. refractum. (2022). Brazilian Journal of Pharmaceutical Sciences, 58. https://doi.org/10.1590/s2175-97902022e20464

Dados de financiamento